Skip to main content Skip to accessibility
This website is not compatible with your web browser. You should install a newer browser. If you live in Jersey and need help upgrading call the States of Jersey web team on 440099.
Government of

Information and public services for the Island of Jersey

L'înformâtion et les sèrvices publyis pouor I'Île dé Jèrri

  • Choose the service you want to log in to:


    Update your notification preferences


    Access government services


    Clear goods through customs or claim relief

  • Talentlink

    View or update your States of Jersey job application

Filgotinib medication (FOI)

Filgotinib medication (FOI)

Produced by the Freedom of Information office
Authored by Government of Jersey and published on 01 December 2021.
Prepared internally, no external costs.


Please can you tell me the total number of patients who have received at least one dose of Filgotinib (Brand name Jyseleca) for rheumatoid arthritis, from the hospital pharmacy system, in the last eight months.


The total number of patients who have received Filgotinib from the hospital pharmacy system in the last eight months was 53 patients.

The hospital pharmacy system does not provide information as to what indication a medication is given for, although rheumatoid arthritis is the licensed indication for Filgotinib.

Back to top
rating button